Best Practices in Biopharmaceutical Medical Publications: Author Transitions

STUDY OVERVIEW

KEY TOPICS

• Guidance for Transitioning Authors
• Joining a Competitor vs Non-competitor
• Guidance for Transitioning KOLs

KEY METRICS

• Does your company provide guidance on if/when an author changing institutions should be removed from a publication?
• What guidance do you provide when an internal author is leaving for a competitor/non-competitor?
• What stage does the publication have to reach to allow a former employee to remain as a lead author?
• When can an internal author who has left your company present publication data at a congress?
• Does your employment contract have sections that clarify authorship rights in the event of an internal author leaving your company?

SAMPLE KEY FINDINGS

• Former employee retained as lead author
  1. For a majority of participants a former employee can remain a lead author if the publication is at or post internal review of drafts stage.
  2. For half of the participants, a former employee joining a competitor or IP sensitivity of the material can be a major barrier to keep this employee as a lead author.

METHODOLOGY

Best Practices, LLC engaged 23 leaders from biopharmaceutical companies and a publication services consultancy in this benchmarking research.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.